A study of mothers and their young babies by neurologists at the University of California, San Francisco (UCSF) has shown that mothers who suffer migraine headaches are more than twice as likely to have babies with colic than mothers without a history of migraines. The work raises the question of whether colic may be an early symptom of migraine and therefore whether reducing stimulation may help just as reducing light and noise can alleviate migraine pain. That is significant because excessive crying is one of the most common triggers for shaken baby syndrome, which can cause death, brain damage and severe disability. "If we can understand what is making the babies cry, we may be able to protect them from this very dangerous outcome, " said Amy Gelfand, MD, a child neurologist with the Headache Center at UCSF who will present the findings at the American Academy of Neurology's 64th Annual Meeting, which takes place in New Orleans in April.
Most people only think about drinking water when they are thirsty; but by then it may already be too late. Even mild dehydration can alter a person's mood, energy level, and ability to think clearly, according to two studies recently conducted at the University of Connecticut's Human Performance Laboratory. The tests showed that it didn't matter if a person had just walked for 40 minutes on a treadmill or was sitting at rest - the adverse effects from mild dehydration were the same. Mild dehydration is defined as an approximately 1.5 percent loss in normal water volume in the body. The test results affirm the importance of staying properly hydrated at all times and not just during exercise, extreme heat, or exertion, says Lawrence E. Armstrong, one of the studies' lead scientists and a professor of physiology in UConn's Department of Kinesiology in the Neag School of Education.
Migraine Self-Management Improved And Migraine-Related Psychological Distress Reduced By painACTION.com
painACTION.com* is a free, non-promotional online program designed to support self-management and improve overall function in people with chronic pain. This study tested painACTION.com's ability to increase the use of self-management skills in people with chronic migraine headaches. A total of 185 participants completed the study. Participants exposed to painACTION.com were more confident that they could prevent headaches and manage headache-related pain and disability, and reported more use of symptom-management strategies, including relaxation and seeking social support, than the control group. They also reported more daily activities and less migraine-related psychological distress, including decreased depression, anxiety, and stress. The full report of this study, "A Randomized Trial of a Web-based Intervention to Improve Migraine Self-Management and Coping" was published in the February 2012 issue of Headache: The Journal of Head and Face Pain (Volume 52, Issue 2).
Brain scans of people under the influence of the psilocybin, the active ingredient in magic mushrooms, have given scientists the most detailed picture to date of how psychedelic drugs work. The findings of two studies being published in scientific journals this week identify areas of the brain where activity is suppressed by psilocybin and suggest that it helps people to experience memories more vividly. In the first study, published in Proceedings of the National Academy of Sciences (PNAS), 30 healthy volunteers had psilocybin infused into their blood while inside magnetic resonance imaging (MRI) scanners, which measure changes in brain activity. The scans showed that activity decreased in "hub" regions of the brain - areas that are especially well-connected with other areas. The second study, due to be published online by the British Journal of Psychiatry on Thursday, found that psilocybin enhanced volunteers' recollections of personal memories, which the researchers suggest could make it useful as an adjunct to psychotherapy.
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE. The new guidelines represent an expert consensus summary, and recommend a contemporary, standardized, and evidence-based approach to investigators conducting and reporting randomised, controlled migraine clinical trials. Migraine clinical research has increased exponentially since the last set of guidelines was published. Clinical researchers and pharmaceutical companies have accumulated further experience, and the trend is towards large, multi-national and multi-centre studies. Given these developments, it was timely to bring the guidelines up to date.